急诊科快速序贯插管中使用琥珀胆碱与罗库溴铵后的插管后镇痛镇静比较
本研究为回顾性多中心队列研究,纳入2020年9月1日至2021年8月31日期间在急诊科接受快速序贯插管并使用琥珀胆碱或罗库溴铵的200例成人患者(每组100例)。主要终点为启动镇痛或镇静的时间,两组中位时间无差异(10 vs 8.5 min,p=0.82),Kaplan-Meier累积概率亦无差异(p=0.17)。插管后60分钟,琥珀胆碱组丙泊酚中位剂量显著更高(20 μg/kg/min vs 10 μg/kg/min,p=0.02),芬太尼剂量亦更高(100 μg vs 84.2 μg,p=0.02)。作者认为需进一步研究评估急诊快速序贯插管后镇静的充分性。
要点
- 急诊快速序贯插管后启动镇痛镇静的中位时间:琥珀胆碱组10 min vs 罗库溴铵组8.5 min,p=0.82,无差异。
- Kaplan-Meier累积概率显示两组启动镇痛镇静时间无差异(p=0.17)。
- 插管后60分钟丙泊酚中位剂量:琥珀胆碱组20 μg/kg/min vs 罗库溴铵组10 μg/kg/min,p=0.02。
- 插管后60分钟芬太尼剂量:琥珀胆碱组100 μg vs 罗库溴铵组84.2 μg,p=0.02。
- 作者认为需进一步研究评估急诊快速序贯插管后镇静的充分性。
适用人群与场景
- 18岁及以上在急诊科接受快速序贯插管并使用琥珀胆碱或罗库溴铵的患者。
- 排除:到急诊前已插管、院外或急诊内发生心脏骤停、罗库溴铵给药后60分钟内使用舒更葡糖的患者。
研究设计与关键结果
- 研究类型:回顾性多中心队列研究;样本量200例(琥珀胆碱组100例,罗库溴铵组100例);研究时段2020年9月1日至2021年8月31日。
- 主要终点启动镇痛或镇静的中位时间:琥珀胆碱组10 min vs 罗库溴铵组8.5 min,p=0.82;Kaplan-Meier累积概率p=0.17。
- 插管后60分钟丙泊酚中位剂量:琥珀胆碱组20 μg/kg/min vs 罗库溴铵组10 μg/kg/min,p=0.02。
- 插管后60分钟芬太尼剂量:琥珀胆碱组100 μg vs 罗库溴铵组84.2 μg,p=0.02。
证据类型、等级与局限
- 证据类型:回顾性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需进一步研究评估急诊快速序贯插管后镇静的充分性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Succinylcholine and rocuronium are the most commonly utilized neuromuscular blocker agents (NMBAs) for rapid sequence intubation (RSI) in the emergency department (ED). The duration of action of rocuronium is significantly longer (∼30 min) compared to succinylcholine (∼10 min) and previous studies have shown that patients receiving rocuronium are more likely to have longer time to sedation initiation following RSI. Furthermore, patients receiving rocuronium may be more likely to experience awareness with paralysis than those receiving succinylcholine. The primary goal for this study was to evaluate the association between NMBA use during RSI and post-intubation sedation and analgesia practices in the ED.
METHODS: This was a retrospective, multicenter cohort study including patients 18 years and older that received succinylcholine or rocuronium during RSI in the ED between September 1, 2020 and August 31, 2021. Patients were excluded if they were intubated prior to ED arrival, experienced an out-of-hospital or in ED cardiac arrest, or received sugammadex within 60 min of rocuronium administration. Patients were screened in reverse chronological order until the targeted sample size was achieved and all data was abstracted from the electronic health record. The primary outcome was the time to initiation of analgesia or sedation. Secondary outcomes included dose of sedatives or analgesia administered at 30- and 60 min, and medications administered for post-intubation sedation or analgesia.
FINDINGS: A total of 200 ED patients were included of which 100 received succinylcholine and 100 received rocuronium. There was no difference in the median time to initiation of analgesia or sedation between the succinylcholine and rocuronium groups (10 vs 8.5 min, p = 0.82) or in Kaplan-Meier cumulative probabilities (p = 0.17). At 60 min post-RSI, those receiving succinylcholine received significantly higher median doses of propofol (20 μg/kg/min vs. 10 μg/kg/min; p = 0.02) and fentanyl [100 μg vs. 84.2 μg; p = 0.02].
CONCLUSION: While no differences were observed in the time to initiation of post-intubation sedation or analgesia in ED patients receiving succinylcholine compared to rocuronium, differences in the intensity of post-intubation regimens was observed. Further investigation is needed to evaluate the adequacy of sedation following RSI in the ED.
参考来源
- Carlson RT, Shah S, Wells E, et al. Post-intubation analgesia and sedation following succinylcholine vs. rocuronium in the emergency department. Am J Emerg Med. 2023. PMID: 37356339. doi:10.1016/j.ajem.2023.06.017
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。